Skip to main content
Journal of Psychiatry & Neuroscience: JPN logoLink to Journal of Psychiatry & Neuroscience: JPN
. 1992 Nov;17(5):195–197.

The addition of intravenous caffeine during an amobarbital interview.

W V McCall 1
PMCID: PMC1188455  PMID: 1489761

Abstract

Although the amobarbital interview is an effective means of temporarily relieving catatonic mutism, some catatonic patients simply fall asleep during an amobarbital interview. We are examining the feasibility of administering intravenous caffeine benzoate during an amobarbital interview to prevent patients from falling asleep. This paper describes an open trial of the administration of 500 mg caffeine benzoate during amobarbital interviews with ten patients. The procedure was well tolerated, but further studies are needed to determine whether or not caffeine is an advantage over amobarbital alone.

Full text

PDF
195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams R., Taylor M. A. Catatonia. A prospective clinical study. Arch Gen Psychiatry. 1976 May;33(5):579–581. doi: 10.1001/archpsyc.1976.01770050043006. [DOI] [PubMed] [Google Scholar]
  2. Acevedo A. G., Smith J. K. Adverse reaction to use of caffeine in ECT. Am J Psychiatry. 1988 Apr;145(4):529–530. doi: 10.1176/ajp.145.4.529b. [DOI] [PubMed] [Google Scholar]
  3. Hurwitz T. A. Narcosuggestion in chronic conversion symptoms using combined intravenous amobarbital and methylphenidate. Can J Psychiatry. 1988 Mar;33(2):147–152. doi: 10.1177/070674378803300214. [DOI] [PubMed] [Google Scholar]
  4. Jaffe Richard, Brubaker Gillian, Dubin William R., Roemer Richard. Caffeine-Associated Cardiac Dysrhythmia During ECT: Report of Three Cases. Convuls Ther. 1990;6(4):308–313. [PubMed] [Google Scholar]
  5. Kellner C. H., Bachman D. L. Olfactory hallucination after intravenous caffeine. Am J Psychiatry. 1992 Mar;149(3):422–422. doi: 10.1176/ajp.149.3.aj1493422. [DOI] [PubMed] [Google Scholar]
  6. Lewis J. L., Santos A. B., Knox E. P. Inducing catatonic patients to eat with daily administration of amobarbital sodium. South Med J. 1989 Oct;82(10):1315–1316. doi: 10.1097/00007611-198910000-00034. [DOI] [PubMed] [Google Scholar]
  7. McCall W. V., Shelp F. E., McDonald W. M. Controlled investigation of the amobarbital interview for catatonic mutism. Am J Psychiatry. 1992 Feb;149(2):202–206. doi: 10.1176/ajp.149.2.202. [DOI] [PubMed] [Google Scholar]
  8. McCall W. Vaughn. The Response to an Amobarbital Interview as a Predictor of Therapeutic Outcome in Patients with Catatonic Mutism. Convuls Ther. 1992;8(3):174–178. [PubMed] [Google Scholar]
  9. Neki J. S., Kishore B. Narcostimulation in depressive states. Am J Psychiatry. 1968 Mar;124(9):1196–1201. doi: 10.1176/ajp.124.9.1196. [DOI] [PubMed] [Google Scholar]
  10. Shale J. H., Gelenberg A. J. The amobarbital interview. Mil Med. 1980 Dec;145(12):825–828. [PubMed] [Google Scholar]
  11. Shapira Baruch, Zohar Joseph, Newman Michael, Drexler Heinz, Belmaker R. H. Potentiation of Seizure Length and Clinical Response to Electroconvulsive Therapy by Caffeine Pretreatment: A Case Report. Convuls Ther. 1985;1(1):58–60. [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Science Publishing

RESOURCES